EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A validated antibody toolbox for ALS research

Riham Ayoubi iD, Emma J MacDougall, Ian McDowell iD, Michael S Biddle iD, Bárbara T Ferreira iD, CongYao Zha iD, Marie-France Dorion, Jay P Ross iD, Sara Gonzalez Bolivar iD, Vera Ruiz Moleon, Charles Alende iD, Vincent Francis und 25 weitere

eLife · 03.11.2026 · 15

DOI: 10.7554/elife.111349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 03.11.2026. Verfasst von Riham Ayoubi und 36 weiteren Autor:innen. Beteiligte Einrichtung: Structural Genomics Consortium, Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montreal, Canada. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Antibodies, C9orf72 Protein. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Motor Neurone Disease Association, Amyotrophic Lateral Sclerosis Association and ALS Society of Canada, Genome Canada, Genome Quebec and Genome Ontario, Québec Consortium for Drug Discovery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A substantial fraction of amyotrophic lateral sclerosis (ALS)-associated proteins remains poorly characterized, in part because of the limited availability of validated research antibodies. We established knockout (KO)-based antibody characterization workflows and demonstrated that widely used antibodies against the major ALS-associated protein C9orf72 lacked specificity (Laflamme et al., 2019). We subsequently scaled this framework to systematically benchmark research antibodies, revealing that up to 61% fail to perform as recommended by manufacturers (Ayoubi et al., 2023b). Here, we extend this approach by establishing the ALS-Reproducible Antibody Platform (ALS-RAP), a comprehensive effort to generate a publicly available dataset of KO-validated antibodies targeting proteins encoded by ALS risk genes. In total, we characterized 303 antibodies against 33 ALS-associated proteins to identify high-quality reagents for use in western blot, immunoprecipitation, and immunofluorescence. Using these antibodies, we profiled protein levels across human induced pluripotent stem cell-derived and primary neurological cell types. These analyses revealed diverse cellular distributions and higher levels of several ALS-associated proteins in glial populations, consistent with emerging evidence for immune contributions to ALS. Together, ALS-RAP provides a validated antibody toolbox and protein expression resource to support the study of ALS-associated proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisAntibodiesC9orf72 ProteinHumansInduced Pluripotent Stem Cells

Stichwörter der Autor:innen

ALSamyotrophic lateral sclerosisantibody characterizationcell biologyhumanneuroscienceopen scienceprotein expression profiling

Substanzen

AntibodiesC9orf72 ProteinC9orf72 protein, human

Autor:innen und Institutionen

  • Structural Genomics Consortium, Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montreal, Canada.
  • Neurodegenerative Diseases Research Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montreal, Canada.
  • NIHR Respiratory Biomedical Research Centre, Department of Respiratory Sciences, University of Leicester, Leicester, United Kingdom.
  • Early Drug Discovery Unit (EDDU), Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montreal, Canada.
  • Department of Genetics, Stanford University School of Medicine, Stanford, United States.
  • Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

ORCID-Profile: Riham Ayoubi, Ian McDowell, Michael S Biddle, Bárbara T Ferreira, CongYao Zha, Jay P Ross, Sara Gonzalez Bolivar, Charles Alende, Maryam Fotouhi, Mathilde Chaineau, Carol X Chen, Valerio E C Piscopo, Irina Shlaifer, Michael Nicouleau, Wen Hwa Lee, Brian D Marsden, Carolyn A Marks, Luke M Healy, Edward A Fon, Harvinder S Virk, Susanne Gräslund, Thomas M Durcan, Peter S McPherson, Carl Laflamme

Förderung

  • Motor Neurone Disease Association, Amyotrophic Lateral Sclerosis Association and ALS Society of Canada
  • Genome Canada, Genome Quebec and Genome Ontario
  • Québec Consortium for Drug Discovery
  • National Centre for the Replacement Refinement and Reduction of Animals in Research
  • Medical Research Council
  • Genome Canada and Ontario Genomics
  • EUbOPEN
  • CIHR

Zitieren

APA

Ayoubi, R., MacDougall, E. J., McDowell, I., Biddle, M. S., Ferreira, B. T., Zha, C., Dorion, M. F., Ross, J. P., Bolivar, S. G., Ruiz Moleon, V., Alende, C., Francis, V., Fotouhi, M., Chaineau, M., Chen, C. X., Piscopo, V. E. C., Soubannier, V., Shlaifer, I., You, Z., …, & Laflamme, C. (2026). A validated antibody toolbox for ALS research. eLife, 15. https://doi.org/10.7554/elife.111349

Vancouver

Ayoubi R, MacDougall EJ, McDowell I, Biddle MS, Ferreira BT, Zha C, et al. A validated antibody toolbox for ALS research. eLife. 2026;15. doi:10.7554/elife.111349

BibTeX
@article{Ayoubi2026,
  author = {Ayoubi, Riham and MacDougall, Emma J and McDowell, Ian and Biddle, Michael S and Ferreira, Bárbara T and Zha, CongYao and Dorion, Marie-France and Ross, Jay P and Bolivar, Sara Gonzalez and Ruiz Moleon, Vera and Alende, Charles and Francis, Vincent and Fotouhi, Maryam and Chaineau, Mathilde and Chen, Carol X and Piscopo, Valerio E C and Soubannier, Vincent and Shlaifer, Irina and You, Zhipeng and Nicouleau, Michael and Keates, Tracy and Lee, Wen Hwa and Marsden, Brian D and Koukouflis, Leonidas and Wigren, Edvard and Marks, Carolyn A and Healy, Luke M and Dion, Patrick A and Rouleau, Guy A and Fon, Edward A and Virk, Harvinder S and Gräslund, Susanne and Gileadi, Opher and Edwards, Aled M and Durcan, Thomas M and McPherson, Peter S and Laflamme, Carl},
  title = {A validated antibody toolbox for ALS research},
  journal = {eLife},
  year = {2026},
  volume = {15},
  doi = {10.7554/elife.111349}
}
Kostenlos starten →